Identification of biomarkers associated with enhanced survival in lung cancer patients undergoing immune checkpoint inhibitor treatment
- DOI
- 10.1016/j.ctarc.2026.101446
- Published
- 2026
- Container
- Cancer Treatment and Research Communications
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctarc.2026.101446,
title = {Identification of biomarkers associated with enhanced survival in lung cancer patients undergoing immune checkpoint inhibitor treatment},
author = {Ilse Visser and Erick Suazo-Zepeda and T.Jeroen N. Hiltermann and Marjolein A. Heuvelmans and Hylke C. Donker and Willemijn J. Maas and Geertruida H. de Bock},
year = {2026},
journal = {Cancer Treatment and Research Communications},
doi = {10.1016/j.ctarc.2026.101446},
url = {https://doi.org/10.1016/j.ctarc.2026.101446}
}RIS
TY - JOUR TI - Identification of biomarkers associated with enhanced survival in lung cancer patients undergoing immune checkpoint inhibitor treatment AU - Ilse Visser AU - Erick Suazo-Zepeda AU - T.Jeroen N. Hiltermann AU - Marjolein A. Heuvelmans AU - Hylke C. Donker AU - Willemijn J. Maas AU - Geertruida H. de Bock PY - 2026 JO - Cancer Treatment and Research Communications DO - 10.1016/j.ctarc.2026.101446 UR - https://doi.org/10.1016/j.ctarc.2026.101446 ER -
APA
Visser, I., Suazo-Zepeda, E., Hiltermann, T. N., Heuvelmans, M. A., Donker, H. C., Maas, W. J., & Bock, G. H. D. (2026). Identification of biomarkers associated with enhanced survival in lung cancer patients undergoing immune checkpoint inhibitor treatment. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101446
Source records
- crossref · retrieved 2026-09-25T05:00:52.861Z